Background: |
TMEFF2 (transmembrane protein with EGF-like and two follistatin-like domains 2), a gene encoding a plasma membrane protein with two follistatin-like domains and one epidermal growth factor–like domain, had limited normal tissue distribution and was highly overexpressed in prostate cancer. The shedded form up-regulates cancer cell proliferation, probably by promoting ERK1/2 phosphorylation. |
Applications: |
ELISA, IHC |
Name of antibody: |
TMEFF2 |
Immunogen: |
Synthetic peptide of human TMEFF2 |
Full name: |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
Synonyms: |
TR; HPP1; TPEF; TENB2; CT120.2 |
SwissProt: |
Q9UIK5 |
ELISA Recommended dilution: |
2000-5000 |
IHC positive control: |
Human breast cancer |
IHC Recommend dilution: |
25-100 |